IDEAYA Biosciences, Inc.

General ticker "IDYA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.5B (TTM average)

IDEAYA Biosciences, Inc. does not follow the US Stock Market performance with the rate: -5.8%.

Estimated limits based on current volatility of 2.0%: low 19.11$, high 19.89$

Factors to consider:

  • Earnings expected soon, date: 2025-05-06 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [10.09$, 25.39$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.48$, 16.78$]

Financial Metrics affecting the IDYA estimates:

  • Negative: Non-GAAP EPS, $ of -3.30 <= 0.04
  • Negative: Operating cash flow per share per price, % of -10.27 <= 1.79
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Shareholder equity ratio, % of 94.22 > 63.75

Similar symbols

Short-term IDYA quotes

2025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-2914151617181920
Price $

Long-term IDYA plot with estimates

51015202530354045Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1.5−1−0.50
IDYAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $50.93MM $23.39MM $7.00MM
Operating Expenses $113.43MM $157.81MM $333.98MM
Operating Income $-62.50MM $-134.43MM $-326.98MM
Non-Operating Income $3.85MM $21.47MM $52.50MM
R&D Expense $89.54MM $129.51MM $294.67MM
Income(Loss) $-58.66MM $-112.96MM $-274.48MM
Profit(Loss)* $-54.81MM $-112.96MM $-274.48MM
Stockholders Equity $349.45MM $621.09MM $1,059.15MM
Inventory $8.32MM $0.00MM $0.00MM
Assets $387.97MM $649.32MM $1,124.09MM
Operating Cash Flow $-87.17MM $-115.22MM $-247.58MM
Capital expenditure $3.44MM $2.37MM $3.86MM
Investing Cash Flow $-33.40MM $-158.46MM $-502.56MM
Financing Cash Flow $97.17MM $362.72MM $677.55MM
Earnings Per Share** $-1.32 $-1.96 $-3.36

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.